Audit Report

TEVA/ PLANTEX TAPI unit of API Division TEVA Pharmaceutical Industries JA – 756

Audit #: JA - 756
Region: Europe
Material: API/Excipients
Company: TEVA/ PLANTEX TAPI unit of API Division TEVA Pharmaceutical Industries
Location: 1 Hakadar St., Industrial Zone, P.O.Box 160, Netanya 4210101 Israel
Date: 31 August 2016

This Rx-360 Audit Report contains the following scope:

The scope of the audit was focused on the main processes as manufacturing, packaging,
labeling, testing and distribution of Allopurinol.
The audit was based on Rx-360 Audit standards for Active Pharmaceutical Ingredients (APIs)
and API Intermediates and also included a supply chain security component based on the Rx360
Consortium Supply Chain Security Checklist.